BioNTech (BNTX) is a publicly traded Healthcare sector company. As of July 5, 2026, BNTX trades at $97.55 with a market cap of $24.67B and a P/E ratio of 0.00. BNTX moved +3.85% today. Year to date, BNTX is +2.38%; over the trailing twelve months it is -9.90%. Its 52-week range spans $79.52 to $129.27. Analyst consensus is strong buy with an average price target of $126.38. Rallies surfaces BNTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BNTX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $97.55 |
| Market Cap | $24.67B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 2.13% |
| 52-Week High | $129.27 |
| 52-Week Low | $79.52 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
13 analysts cover BNTX: 0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $126.38.